These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1945038

  • 1. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B, Micheletti G, Warter JM, Kempf E, Di Scala G.
    Neurosci Lett; 1991 Jul 22; 128(2):177-81. PubMed ID: 1945038
    [Abstract] [Full Text] [Related]

  • 2. Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
    Owolabi AR, Akanmu MA, Ukponmwan OE.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul 22; 378(1):117-24. PubMed ID: 18408917
    [Abstract] [Full Text] [Related]

  • 3. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 22; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 4. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M.
    Pharmacol Res Commun; 1977 Apr 22; 9(4):381-9. PubMed ID: 559310
    [No Abstract] [Full Text] [Related]

  • 5. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 22; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR, Kim C.
    Res Commun Chem Pathol Pharmacol; 1978 Jul 22; 21(1):37-44. PubMed ID: 567367
    [Abstract] [Full Text] [Related]

  • 7. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC, Delini-Stula AA.
    Eur J Pharmacol; 1979 May 15; 55(4):363-73. PubMed ID: 572774
    [Abstract] [Full Text] [Related]

  • 8. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine.
    Cuomo V, Cagiano R, Mocchetti I, Coen E, Cattabeni F, Racagni G.
    Psychopharmacology (Berl); 1983 May 15; 81(3):239-43. PubMed ID: 6417713
    [Abstract] [Full Text] [Related]

  • 9. Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol.
    Cuomo V, Cagiano R, Coen E, Mocchetti I, Cattabeni F, Racagni G.
    Psychopharmacology (Berl); 1981 May 15; 74(2):166-9. PubMed ID: 6791221
    [Abstract] [Full Text] [Related]

  • 10. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 15; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 11. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J, Coviella IL, Wurtman RJ.
    Neuropharmacology; 1984 Dec 15; 23(12A):1403-6. PubMed ID: 6543245
    [Abstract] [Full Text] [Related]

  • 12. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H, Baggiolini M, Burki HR, Lauener H, Ruch W, Stille G.
    Eur J Pharmacol; 1973 Jun 15; 22(3):287-94. PubMed ID: 4738903
    [No Abstract] [Full Text] [Related]

  • 13. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
    Wachtel H, Kehr W, Sauer G.
    Life Sci; 1983 Dec 26; 33(26):2583-97. PubMed ID: 6607392
    [Abstract] [Full Text] [Related]

  • 14. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG, Bellows EP, Barnes DE, Lombrozo L.
    Psychopharmacology (Berl); 1990 Dec 26; 101(4):519-24. PubMed ID: 2388975
    [Abstract] [Full Text] [Related]

  • 15. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V, Ahlenius S, Magnusson O, Fowler CJ.
    Pharmacol Biochem Behav; 1987 May 26; 27(1):159-64. PubMed ID: 3615537
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
    Ibii N, Ikeda M, Takahara Y, Eigyo M, Akiyoshi T, Matsushita A.
    Peptides; 1989 May 26; 10(4):779-83. PubMed ID: 2587420
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O, Fowler CJ, Köhler C, Ogren SO.
    Neuropharmacology; 1986 Feb 26; 25(2):187-97. PubMed ID: 2939362
    [Abstract] [Full Text] [Related]

  • 18. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ, Korf J.
    Psychopharmacology (Berl); 1986 Feb 26; 90(1):54-7. PubMed ID: 3094062
    [Abstract] [Full Text] [Related]

  • 19. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    Life Sci; 1978 Aug 14; 23(6):611-5. PubMed ID: 692284
    [No Abstract] [Full Text] [Related]

  • 20. Differential biochemical and behavioral effects of single and chronic administration of amphetamine and apomorphine.
    Bernardi MM, Scavone C.
    Gen Pharmacol; 1985 Aug 14; 16(4):407-10. PubMed ID: 4043718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.